Utama › Kardiomiopati Hipertrofik › Texas
Kajian klinikal Kardiomiopati Hipertrofik di Texas
4 kajian untuk Kardiomiopati Hipertrofik sedang mencari peserta di lokasi di Texas.
Bandar di Texas
Teks kajian rasmi (Bahasa Inggeris)
BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy
- LIONHEART-HCM Site 0121, Plano
Mengambil pesertaFasa 3
Umur 18 hingga 85 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07755904A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- North Texas Cardiology Center, Dallas
- Baylor Scott & White Research Institute, Dallas
- The Methodist Hospital, Methodist Cancer Cencer, Houston
- dan 3 lagi
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT05489705A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, Houston
- Imbria Investigational Site, Plano
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Mei 2026 · NCT07023614Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
- Houston Methodist Hospital, Houston
Mengambil pesertaFasa 1/2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 19 Mac 2026 · NCT05836259Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.